Biomarkers that help patients to choose the best treatment option, play a key role in drug development and precision medicine. The talk introduced the Virtual Twin Method by Foster et al. (2011). It is a multivariate, tree-based method that identifies patients who may...

The Engaged Database - TED With TED, users have access to a straightforward tool, based upon the European Medicines Agency (EMA) inspection database, which allows the comparison of the results of one or more audits, to a large number of audit results. The Engaged...

Welcome our teammates Hans and Bobby! We are very glad to welcome Hans Bauer and Bobby Reidy in our team. Hans and Bobby are both professionals with work experience and excellent education from first-class universities. They will support our clients in the areas of...

We are proud to announce that due to our remarkable growth in biostatistics and statistical programming, we were recently moving to a new office location. We will continue to offer the same costumer-friendly service from our new address at Aschauer Str. 26b in Munich,...

Staburo participated in the APF meeting on 24 November 2017 in Freiburg. This year, the APF was hosted by Roche. Speakers from pharmaceutical industry, academia and regulatory agencies discussed important topics on estimands, safety and Health Technlogy Assessment....

Big steps for Staburo in 2017 Last year was very successful for our company. Our major milestones were: Strategy workshop with Mission & Vision for 2022 Further internationalization with additional US, EU and UK projects New big pharma & new biomarker project...

The 2nd Annual Biosimilars Forum was hosted in Budapest in October 2017. Clinicians, statisticians and regulatory representatives from around the world gathered here, to share with each other their perspectives on this hot topic of research, in lectures and informal...

Staburo took part in the WiMa17 Congress at the University Ulm. The WiMa Congress is a networking forum for companies and students from a mathematics, finance, IT, and biometry background. At the WiMa Congress, companies have the opportunity to present themselves, get...

Imagine we had a cure for cancer, but patients don't receive it? This sounds very disturbing, but it can happen to the most effective drugs, if Crossover Correction is not taken into account. To share our profound expertise on this topic, our Head of Biostatistics Dr....